In vivo protein n-acylation
AssigneeDuke University
InventorsMichael David Lynch, Romel Menacho Melgar
Life of this patent
Estimating the term…
Loading patent…
AssigneeDuke University
InventorsMichael David Lynch, Romel Menacho Melgar
Estimating the term…
Described are a genetically modified microorganism and corresponding methods and products. The genetically modified microorganism may include a first gene that encodes an acyl transferase and a second gene that encodes a peptide or protein. One or both of the first and second gene may be heterologous. The genetically modified microorganism may include a modified acyl-CoA biosynthetic pathway configured for one or more of: inducible biosynthesis of an acyl-CoA and over-accumulation of the acyl-CoA. The genetically modified microorganism may be effective upon fermentation to cause acylation of the peptide or protein by the acyl transferase using the acyl-CoA to provide a N-acylated peptide or protein product.
-74. (canceled)
A method of in vivo acylation of a target peptide or protein in an E. coli microorganism, comprising:
Dependencies are inferred from the claim text.